Skip to content

Keratoconus Detection Using MS39 and Pentacam

Keratoconus Detection Using MS39 and Pentacam - a Retrospective Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05604443
Acronym
KKMS39Penta
Enrollment
173
Registered
2022-11-03
Start date
2022-12-28
Completion date
2023-05-01
Last updated
2023-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Keratoconus

Keywords

Keratoconus, Pentacam, MS39

Brief summary

This retrospective study aims to investigate whether the MS39 and Pentacam are delivering comparable results in the diagnosis of keratoconus. In the future, these measurement devices could be interchangeable in usage.

Detailed description

Keratoconus is a degenerative pathology of the cornea, which tends to progress. It comes along with central and paracentral thinning of the cornea as well as with an apical protrusion of the cornea. Keratoconus leads to vision loss. This pathology is diagnosed by using CE certified OCT technology in order to map the topography of the cornea. This process constitutes a really important step in the line of management of the keratoconus. MS39 and Pentacam are used for detection. Retrospectively, data will be investigated, in order to see if these measurement devices deliver comparable results. In the future, these measurement devices could be interchangeable in usage.

Interventions

OTHERretrospective analyze

retrospective analyze of MS39 and Pentacam images

Sponsors

Johannes Kepler University of Linz
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
14 Years to 100 Years

Inclusion criteria

* age older than 14 years * patients who show up at Keratokonus consultation hours

Exclusion criteria

* age younger than 14 years * age older than 100 years

Design outcomes

Primary

MeasureTime frameDescription
topography of the cornea12 monthsmeasurement of the topography of the cornea with MS39 and Pentacam

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026